Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double‐blind, placebo‐controlled trial-Reference-Cited by-同舟云学术

Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double‐blind, placebo‐controlled trial

Published:2022-01-23 Issue:1 Volume:42 Page:92-104
ISSN:2574-173X
Container-title:Neuropsychopharmacology Reports
language:en
Short-container-title:Neuropsychopharm Rep

Author:

Kotajima‐Murakami Hiroko¹²,Takano Ayumi²³,Hirakawa Shinya⁴,Ogai Yasukazu⁵,Funada Daisuke⁶^ORCID,Tanibuchi Yuko²⁷^ORCID,Ban Eriko²,Kikuchi Minako²,Tachimori Hisateru⁴^ORCID,Maruo Kazushi⁸,Kawashima Takahiro⁴,Tomo Yui⁴,Sasaki Tsuyoshi⁹,Oi Hideki¹⁰,Matsumoto Toshihiko²,Ikeda Kazutaka¹²^ORCID

Affiliation:

1. Addictive Substance Project Tokyo Metropolitan Institute of Medical Science Tokyo Japan

2. Department of Drug Dependence Research National Institute of Mental Health National Centre of Neurology and Psychiatry Tokyo Japan

3. Department of Mental Health and Psychiatric Nursing Tokyo Medical and Dental University Tokyo Japan

4. Department of Clinical Data Science Clinical Research & Education Promotion Division National Centre of Neurology and Psychiatry Tokyo Japan

5. Social Psychiatry and Mental Health Faculty of Medicine University of Tsukuba Ibaraki Japan

6. Department of Psychiatry National Centre Hospital National Centre of Neurology and Psychiatry Tokyo Japan

7. Department of Psychiatry Chiba Hospital Chiba Japan

8. Department of Biostatistics Faculty of Medicine University of Tsukuba Ibaraki Japan

9. Department of Child Psychiatry Chiba‐University Hospital Chiba Japan

10. Department of Clinical Research Promotion Translational Medical Centre National Centre of Neurology and Psychiatry Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Mitsubishi Foundation

Smoking Research Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Clinical Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/npr2.12232

Reference47 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. United Nations Office of Drugs and Crime.World Drug Report. 2018: p.54‐57. Accessed October 20 2021. Available from:https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_3_DRUG_MARKETS.pdf

3. Social and legal factors related to drug abuse in the United States and Japan;Greberman SB;Public Health Rep,1994

4. National Police Agency.White Papers of the National Police Agency.2016: p. 144. Accessed October 20 2021. Available from:https://www.npa.go.jp/hakusyo/h28/index.html

5. Atrial G protein-activated K+ channel: expression cloning and molecular properties.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting NMDA receptors with an antagonist is a promising therapeutic strategy for treating neurological disorders;Behavioural Brain Research;2024-08

2. Indazole as a Phenol Bioisostere: Structure–Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists;Journal of Medicinal Chemistry;2023-08-15

3. GIRK Channels as Candidate Targets for the Treatment of Substance Use Disorders;Biomedicines;2022-10-13